| Title |
Inhaled chemotherapy in lung cancer: future concept of nanomedicine
|
|---|---|
| Published in |
International Journal of Nanomedicine, March 2012
|
| DOI | 10.2147/ijn.s29997 |
| Pubmed ID | |
| Authors |
Paul Zarogoulidis, Ekaterini Chatzaki, Konstantinos Porpodis, Kalliopi Domvri, Wolfgang Hohenforst-Schmidt, Eugene P Goldberg, Nikos Karamanos, Konstantinos Zarogoulidis |
| Abstract |
Regional chemotherapy was first used for lung cancer 30 years ago. Since then, new methods of drug delivery and pharmaceuticals have been investigated in vitro, and in animals and humans. An extensive review of drug delivery systems, pharmaceuticals, patient monitoring, methods of enhancing inhaled drug deposition, safety and efficacy, and also additional applications of inhaled chemotherapy and its advantages and disadvantages are presented. Regional chemotherapy to the lung parenchyma for lung cancer is feasible and efficient. Safety depends on the chemotherapy agent delivered to the lungs and is dose-dependent and time-dependent. Further evaluation is needed to provide data regarding early lung cancer stages, and whether regional chemotherapy can be used as neoadjuvant or adjuvant treatment. Finally, inhaled chemotherapy could one day be administered at home with fewer systemic adverse effects. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 1 | 33% |
| Unknown | 2 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 196 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 3 | 2% |
| Greece | 1 | <1% |
| Canada | 1 | <1% |
| Unknown | 191 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 37 | 19% |
| Researcher | 27 | 14% |
| Student > Master | 25 | 13% |
| Student > Bachelor | 14 | 7% |
| Professor | 12 | 6% |
| Other | 36 | 18% |
| Unknown | 45 | 23% |
| Readers by discipline | Count | As % |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutical Science | 34 | 17% |
| Medicine and Dentistry | 25 | 13% |
| Engineering | 20 | 10% |
| Agricultural and Biological Sciences | 19 | 10% |
| Biochemistry, Genetics and Molecular Biology | 11 | 6% |
| Other | 34 | 17% |
| Unknown | 53 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 October 2022.
All research outputs
#6,443,331
of 25,374,647 outputs
Outputs from International Journal of Nanomedicine
#653
of 4,123 outputs
Outputs of similar age
#40,617
of 168,145 outputs
Outputs of similar age from International Journal of Nanomedicine
#22
of 99 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 4,123 research outputs from this source. They receive a mean Attention Score of 4.7. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 168,145 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 99 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.